The combination therapy significantly increased the infiltration of CD4+ T cells, CD8+ T cells, as well as the population of IFN-γ+ CD4+ T cells and IFN-γ+ CD8+ T cells in the tumor immune microenvironment compared to those in the other groups (Fig. 1d, Supplementary Fig. 3a, b). Here, CD8A is linked to neoplasm.